Type 2 medication programme to boost GP and community nurse education
A trio of top experts will give primary care services a “helping hand” to better understand a specific type 2 diabetes medication.
Leicester researchers have published a new training programme module to help GPs and community nurses know more about glucagon-like peptide 1 receptor agonists (GLP-1 RAs).
‘New Decade, New Therapies: Simplifying the Complex’ is a CPD-accredited course looking at GLP-1 RA treatments, which could vastly improve health outcomes for people with type 2 diabetes.
The class of drug is very effective at lowering blood sugar levels and has also been found to improve heart health and kidney function. However, some people may be better suited to treatment with GLP-1 RAs than others.
The first module launched in March, and the second session will once again feature webcast discussions between top diabetes researchers Professor Melanie Davies CBE, Professor Kamlesh Khunti and Dr Samuel Seidu, with pre and post multiple choice questions for the user to complete.
They will discuss the practical aspects of initiation and titrations of GLP-1RA and their combinations with other glucose lowering therapies.
Profesor Kamlesh Khunti, Professor of Primary Care Diabetes and Vascular Medicine at the University of Leicester and also Co-Director of the Leicester Diabetes Centre, said: “COVID-19 is very new to all of us and seems to be affecting people with diabetes much more disproportionately and also appears to lead to worse outcomes, so it’s vital we ensure all our patients are as healthy as they can be.
“This module will cover the key aspects from the latest evidence on GLP-1 RA treatments.”
Professor Davies, Professor of Diabetes Medicine at the University of Leicester and Co-Director of the Leicester Diabetes Centre at Leicester General Hospital, said: “This module will provide primary care staff with a helping hand so they can treat people with type 2 diabetes more effectively .
“Patient-centred care has never been so important and because of the rapid availability of new therapies in this area, and the opportunities to combine them in more innovative ways, it is really important that primary care teams are supported and understand how they can optimise the opportunities offered with the availability of GLP-1 RA’s.”
This module is just one of a number of resources for healthcare professionals and patients to support those with diabetes remotely during the coronavirus crisis.
Others include the free release of the MyDesmond app, an intereactive education and support programme for people with type 2 diabetes.
In October the third and final module will be available and covers innovations in GLP-1RAs. There will also be accompanying presentation resources to further support the learning throughout the course.
To access the course, click here.